देश: आर्मेनिया
भाषा: अंग्रेज़ी
स्रोत: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
orlistat
KRKA-RUS LLC
A08AB01
orlistat
120mg
capsules
(21/3x7/) in blister, (21/1x21/), in blister, (42/6x7/) in blister, (42/2x21/), in blister
Prescription
Registered
2016-05-12
1.3.1 Orlistat SPC, Labeling and Package Leaflet AM SmPCPIL156212_1 15.10.2020 – Updated: 15.10.2020 Page 1 of 7 1. NAME OF THE MEDICINAL PRODUCT Orsoten ® 120 mg capsules 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each capsule contains 120 mg orlistat. For Excipients see section 6.1. 3. PHARMACEUTICAL FORM Hard capsules are made from hypromellose. The body and the cap of the capsule are white colour or white with yellow cast. The content of the capsules are micro granules or mixture of powder and micro granules white or almost white colour. The presence of agglutinate agglomerates, which quickly dissipate at gently tension, is permitted. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Orsoten ® is indicated for the long term treatment of obese patients with a body mass index (BMI) greater or equal to 30 kg/m 2 , or overweight patients (BMI ≥ 28 kg/m 2 ), including those with associated risk factors, in conjunction with a mildly hypocaloric diet. Treatment with orlistat should be discontinued after 12 weeks if patients have been unable to lose at least 5% of the body weight as measured at the start of therapy. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION The recommended dose of orlistat is one 120 mg capsule taken per os with water immediately before, during or up to one hour after each main meal. If a meal is missed or contains no fat, the dose of orlistat may be omitted. The patient should be on a nutritionally balanced, mildly hypocaloric diet that contains approximately 30% of calories from fat. It is recommended that the diet should be rich in fruit and vegetables. The daily intake of fat, carbohydrate and protein should be distributed over three main meals. Doses of orlistat above 120 mg three times daily have not been shown to provide additional benefit. The effect of orlistat results in an increase in faecal fat as early as 24 to 48 hours after dosing. Upon discontinuation of therapy, faecal fat content usually returns to pre-treatment levels, within 48 to 72 hours. Special populations The effect पूरा दस्तावेज़ पढ़ें